Silence Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLN and other ETFs, options, and stocks.About SLN
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells.
CEOCraig Allen Tooman
CEOCraig Allen Tooman
Employees116
Employees116
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded1994
Founded1994
Employees116
Employees116
SLN Key Statistics
Market cap306.13M
Market cap306.13M
Price-Earnings ratio-3.78
Price-Earnings ratio-3.78
Dividend yield—
Dividend yield—
Average volume367.04K
Average volume367.04K
High today$6.51
High today$6.51
Low today$6.20
Low today$6.20
Open price$6.48
Open price$6.48
Volume155.84K
Volume155.84K
52 Week high$8.08
52 Week high$8.08
52 Week low$1.97
52 Week low$1.97
Stock Snapshot
Silence Therapeutics(SLN) stock is priced at $6.32, giving the company a market capitalization of 306.13M. It carries a P/E multiple of -3.78.
On 2025-12-14, Silence Therapeutics(SLN) stock traded between a low of $6.20 and a high of $6.51. Shares are currently priced at $6.32, which is +1.9% above the low and -2.9% below the high.
The Silence Therapeutics(SLN)'s current trading volume is 155.84K, compared to an average daily volume of 367.04K.
During the past year, Silence Therapeutics(SLN) stock moved between $1.97 at its lowest and $8.08 at its peak.
During the past year, Silence Therapeutics(SLN) stock moved between $1.97 at its lowest and $8.08 at its peak.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
0%
Sell
16.7%